Skip to main navigation Skip to search Skip to main content

Risks associated with homologous blood transfusion

  • Louis M. Aledort

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

A number of risks attend the transfusion of homologous blood products, chief among them the possibility of infection with viral or bacterial agents that may survive routine screening and processing of donor blood, Infectious agents include B, non-A, non-B, and delta hepatitis viruses, human immunodeficiency virus, cytomegalovirus, and Epstein-Barr virus. In many clinical settings, alternatives to the use of homologous blood are available. The author reviews the most serious infectious agents found in donor blood and summarizes the options to homologous blood use.

Original languageEnglish
Pages (from-to)2-6
Number of pages5
JournalJournal of Cardiothoracic Anesthesia
Volume2
Issue number6
DOIs
StatePublished - 1988

Fingerprint

Dive into the research topics of 'Risks associated with homologous blood transfusion'. Together they form a unique fingerprint.

Cite this